PapersPMID:32384902
Effects of fish oil supplementation on glucose control and lipid levels among patients with type 2 diabetes mellitus: a Meta-analysis of randomized controlled trials.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- meta-analysis
- Population, every finding
- Adults with type 2 diabetes (820 participants across 12 randomized trials, 15 lipid datasets); fish oil versus placebo oils, trials lasting 3 weeks to 6 months
What moved
How to read these marks →“However, compared to placebo, fish oil supplementation significantly decreased TG level by − 0.40 (95%CI: − 0.53 to-0.28, I2 = 0%, p < 0.05), and increased HDL cholesterol level by 0.21 (95%CI: 0.05 to 0.37, I2 = 37.1%, p < 0.05).”
- Increases HDL cholesterol
moderate
- Interests
- Industry funded
- Decreases triglycerides
moderatereplicated ×2
- Interests
- Industry funded
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Patients with type 2 diabetes mellitus in 12 RCTs of fish oil supplementation vs placebo (abstract only)
- Participants
- not reported
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 10